Saturday, July 11, 2026
🇺🇸 FDA

Intelligence · Clinical pipeline

Phase III Pipeline Programs

Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Programs 5,427
Sponsors 1,771
Drugs 4,798

Quick answer

NovaPharmaNews tracks 5,427 phase iii pharmaceutical pipeline programs from ClinicalTrials.gov. Late-stage pivotal and registrational clinical programs nearing regulatory submission.

Top sponsors

Pipeline programs

Page 54 of 114

  1. Iron (27 mg) - folic acid (600 ug)

    United Therapeutics Europe Ltd

    Infant Mortality

    phase 3 other completed

    1 trial

  2. Isatuximab SAR650984

    Sanofi Pasteur

    Plasma Cell Myeloma

    phase 3 small molecule active

    1 trial

  3. Isavuconazole

    Astellas Pharma Inc

    Candidiasis, Invasive

    phase 3 small molecule completed

    1 trial

  4. Isoniazid with Ethambutol

    United Therapeutics Europe Ltd

    Human Immunodeficiency Virus

    phase 3 small molecule completed

    1 trial

  5. Itepekimab (SAR440340)

    Regeneron UK Limited

    Chronic Rhinosinusitis With Nasal Polyps

    phase 3 small molecule active

    4 trials

  6. Itepekimab SAR440340

    Regeneron UK Limited

    Chronic Obstructive Pulmonary Disease

    phase 3 small molecule active

    4 trials

  7. Itepekimab, Matched Placebo for test product

    Sanofi-aventis Healthcare Pty Ltd

    Chronic Obstructive Pulmonary Disease

    phase 3 small molecule active

    1 trial

  8. Itepekimab, Matched placebo for test product

    Sanofi-aventis Healthcare Pty Ltd

    Chronic rhinosinusitis with nasal polyps

    phase 3 small molecule active

    1 trial

  9. Itepekimab, Matched placebo for test product

    Sanofi-aventis Healthcare Pty Ltd

    Chronic Obstructive Pulmonary Disease

    phase 3 small molecule active

    1 trial

  10. Ivacaftor

    Vertex Pharmaceuticals (Australia) Pty.

    Cystic Fibrosis

    phase 3 small molecule completed

    16 trials

  11. Ivonescimab 10 mg/kg

    Summit Therapeutics

    Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)

    phase 3 small molecule active

    1 trial

  12. Ivonescimab Injection

    Summit Therapeutics

    Non-Small Cell Lung Cancer

    phase 3 mab active

    2 trials

  13. Ixabepilone + Capecitabine

    Semnur Pharmaceuticals

    Breast Cancer

    phase 3 small molecule completed

    1 trial

  14. Ixazomib

    Takeda

    Relapsed Multiple Myeloma

    phase 3 small molecule completed

    1 trial

  15. Ixazomib Citrate

    Takeda

    Multiple Myeloma

    phase 3 small molecule completed

    2 trials

  16. J1I-MC-GZBO

    Eli Lilly Co.

    Overweight, Obesity

    phase 3 small molecule active

    1 trial

  17. J1I-MC-GZBP

    Eli Lilly Co.

    Obesity

    phase 3 small molecule active

    1 trial

  18. J1I-MC-GZQD

    Eli Lilly Co.

    Overweight, Chronic Low Back Pain (CLBP), Obesity

    phase 3 small molecule active

    1 trial

  19. J2A-MC-GZGW

    Eli Lilly Co.

    Type 2 Diabetes

    phase 3 small molecule active

    1 trial

  20. J2A-MC-GZPL

    Eli Lilly Co.

    Hypertension

    phase 3 small molecule active

    1 trial

  21. J2A-MC-GZPO

    Eli Lilly Co.

    GZP1, GZP2: Obesity, Overweight GZP2: Type 2 Diabetes

    phase 3 small molecule active

    1 trial

  22. J2A-MC-GZPR

    Eli Lilly Co.

    Peripheral Arterial Disease

    phase 3 small molecule active

    1 trial

  23. J2A-MC-GZPS

    Eli Lilly Co.

    Urinary Incontinence, Stress

    phase 3 small molecule active

    1 trial

  24. J2A-MC-GZPT

    Eli Lilly Co.

    Osteoarthritis

    phase 3 small molecule active

    1 trial

  25. J2A-MC-GZPW

    Eli Lilly Co.

    Chronic Kidney Disease, Atherosclerosis Cardiovascular Disease

    phase 3 small molecule active

    1 trial

  26. J2G-MC-JZJB

    Eli Lilly Co.

    RET-Mutant Medullary Thyroid Cancer

    phase 3 small molecule active

    1 trial

  27. J2G-MC-JZJC

    Eli Lilly Co.

    Advanced or Metastatic RET Fusion-Positive Non-Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  28. J2G-MC-JZJX

    Eli Lilly Co.

    RET fusion-Positive NSCLC

    phase 3 small molecule active

    1 trial

  29. J2J-OX-JZLC

    Eli Lilly Co.

    Breast Cancer

    phase 3 small molecule active

    1 trial

  30. J2S-MC-GZME

    Eli Lilly Co.

    Alcohol Use Disorder

    phase 3 small molecule active

    1 trial

  31. J2T-MC-KGBT

    Eli Lilly Co.

    Perennial Allergic Rhinitis (PAR)

    phase 3 small molecule active

    1 trial

  32. J2T-MC-KGBU

    Eli Lilly Co.

    Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

    phase 3 small molecule active

    1 trial

  33. J3M-MC-JZQB

    Eli Lilly Co.

    Stage IIIB-IIIC or Stage IV KRAS G12C-mutant non-small cell lung cancer

    phase 3 small molecule active

    1 trial

  34. J3M-MC-JZQH

    Eli Lilly Co.

    Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  35. J3R-MC-YDAF

    Eli Lilly Co.

    Obesity, Overweight

    phase 3 small molecule active

    1 trial

  36. J3R-MC-YDAG

    Eli Lilly Co.

    Obesity, Overweight

    phase 3 small molecule active

    1 trial

  37. J3R-MC-YDAL

    Eli Lilly Co.

    Overweight, Obesity

    phase 3 small molecule active

    1 trial

  38. J3R-MC-YDAO

    Eli Lilly Co.

    Overweight, Obesity, Sleep Apnea, Obstructive

    phase 3 small molecule active

    1 trial

  39. J4G-MC-JZVD

    Eli Lilly Co.

    Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis

    phase 3 small molecule active

    1 trial

  40. J5E-MC-JZXB

    Eli Lilly Co.

    Fallopian Tube Neoplasms, Peritoneal Neoplasms, Ovarian Neoplasms, Neoplasm Metastasis

    phase 3 small molecule active

    1 trial

  41. J6M-MC-JSGD

    Eli Lilly Co.

    Neoplasm Metastasis, Breast Neoplasms

    phase 3 small molecule active

    1 trial

  42. JDQ443

    Novartis Pharmaceuticals

    Non-Small Cell Lung Cancer

    phase 3 small molecule active

    1 trial

  43. JEVTANA 60 mg concentrate and solvent for solution for infusion.

    Ningbo Cancer Hospital

    Patients with localized prostate cancer and high-risk features of relapse.

    phase 3 small molecule active

    1 trial

  44. JNJ-54767414

    Janssen-Cilag International N.V.

    Precancerous form of blood cancer in the bone marrow

    phase 3 small molecule active

    1 trial

  45. JNJ-56021927

    Ningbo Cancer Hospital

    High-risk biochemically-relapsed prostate adenocarcinoma following radical prostatectomy.

    phase 3 small molecule active

    1 trial

  46. JNJ-67896062, JNJ-67896062

    Lacuna Pharma Pty Ltd

    Pediatric pulmonary arterial hypertension

    phase 3 small molecule active

    1 trial

  47. JNJ-67953964

    Janssen-Cilag International N.V.

    Major Depressive Disorder

    phase 3 small molecule active

    1 trial

  48. JNJ-77242113

    Janssen Cilag International NV

    Plaque Psoriasis

    phase 3 small molecule active

    1 trial

Frequently asked questions

How many Phase III pipeline programs are in the directory?

5,427 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.